1. Home
  2. HALO vs NYT Comparison

HALO vs NYT Comparison

Compare HALO & NYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • NYT
  • Stock Information
  • Founded
  • HALO 1998
  • NYT 1851
  • Country
  • HALO United States
  • NYT United States
  • Employees
  • HALO N/A
  • NYT N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • NYT Newspapers/Magazines
  • Sector
  • HALO Health Care
  • NYT Consumer Discretionary
  • Exchange
  • HALO Nasdaq
  • NYT Nasdaq
  • Market Cap
  • HALO 7.4B
  • NYT 8.6B
  • IPO Year
  • HALO N/A
  • NYT N/A
  • Fundamental
  • Price
  • HALO $65.87
  • NYT $53.63
  • Analyst Decision
  • HALO Buy
  • NYT Buy
  • Analyst Count
  • HALO 9
  • NYT 6
  • Target Price
  • HALO $63.78
  • NYT $55.50
  • AVG Volume (30 Days)
  • HALO 2.0M
  • NYT 1.7M
  • Earning Date
  • HALO 05-06-2025
  • NYT 05-07-2025
  • Dividend Yield
  • HALO N/A
  • NYT 1.34%
  • EPS Growth
  • HALO 55.40
  • NYT 21.26
  • EPS
  • HALO 3.76
  • NYT 1.83
  • Revenue
  • HALO $1,084,306,000.00
  • NYT $2,600,814,000.00
  • Revenue This Year
  • HALO $20.06
  • NYT $8.41
  • Revenue Next Year
  • HALO $24.20
  • NYT $5.95
  • P/E Ratio
  • HALO $17.56
  • NYT $29.38
  • Revenue Growth
  • HALO 25.64
  • NYT 6.90
  • 52 Week Low
  • HALO $41.28
  • NYT $44.83
  • 52 Week High
  • HALO $70.51
  • NYT $58.16
  • Technical
  • Relative Strength Index (RSI)
  • HALO 58.99
  • NYT 73.50
  • Support Level
  • HALO $58.38
  • NYT $51.31
  • Resistance Level
  • HALO $70.51
  • NYT $53.35
  • Average True Range (ATR)
  • HALO 2.50
  • NYT 1.04
  • MACD
  • HALO 0.88
  • NYT 0.23
  • Stochastic Oscillator
  • HALO 64.61
  • NYT 96.13

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About NYT New York Times Company (The)

New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.

Share on Social Networks: